These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 15464185

  • 1. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A, Nunn AJ, Enarson DA.
    Lancet; ; 364(9441):1244-51. PubMed ID: 15464185
    [Abstract] [Full Text] [Related]

  • 2. Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
    Nunn AJ, Jindani A, Enarson DA, Study A investigators.
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):741-5. PubMed ID: 21575292
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
    Indian J Tuberc; 2007 Apr; 54(2):84-90. PubMed ID: 17575680
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.
    Okwera A, Johnson JL, Luzze H, Nsubuga P, Kayanja H, Cohn DL, Nunn P, Ellner JJ, Whalen CC, Mugerwa RD.
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):39-44. PubMed ID: 16466035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T, Rehman F, Mitchison DA, Sarma GR, Reetha AM, Prabhaker R, Tuberculosis Research Centre, Indian Council of Medical Research.
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [Abstract] [Full Text] [Related]

  • 16. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
    Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
    [Abstract] [Full Text] [Related]

  • 17. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract] [Full Text] [Related]

  • 18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE, Zierski M, Graczyk J, Bek E, Farer LS.
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [Abstract] [Full Text] [Related]

  • 20. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.